Daily Stock Analysis, ACRS, Aclaris Therapeutics Inc, priceseries

Aclaris Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
25.94
Close
25.51
High
26.29
Low
25.41
Previous Close
25.97
Daily Price Gain
-0.46
YTD High
33.25
YTD High Date
Mar 8, 2017
YTD Low
22.31
YTD Low Date
Aug 10, 2017
YTD Price Change
-2.44
YTD Gain
-8.73%
52 Week High
33.25
52 Week High Date
Mar 8, 2017
52 Week Low
20.15
52 Week Low Date
Nov 3, 2016
52 Week Price Change
0.65
52 Week Gain
2.61%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 12. 2016
23.24
Oct 4. 2016
24.54
16 Trading Days
5.61%
Link
Company Information
Stock Symbol
ACRS
Exchange
NasdaqGS
Company URL
http://http://www.aclaristx.com
Company Phone
484-321-5554
CEO
Neal S. Walker
Headquarters
Pennsylvania
Business Address
SUITE 400, 101 LINDENWOOD DRIVE, MALVERN, PA 19355
Sector
Equity
Industry Category
-
Industry Group
-
CIK
0001557746
About

Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology.

Description

Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.